;
Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Sage Therapeutics completes IPO

    Sage Therapeutics Inc. (NASDAQ:SAGE), Cambridge, Mass. Business: Neurology Date completed: 2014-07-17 Type: IPO Raised: $103.5 million Shares: 5.8 million Price: $18 Shares after offering: 25.7 million Underwriters: …

    Published on 7/28/2014
  • Synlogic completes venture financing

    Synlogic Inc., Cambridge, Mass. Business: Gastrointestinal Date completed: 2014-07-22 Type: Venture financing Raised: Not disclosed Investors: Atlas Ventures; New Enterprise Associates Note: The company raised an …

    Published on 7/28/2014
  • Tribute Pharmaceuticals completes follow-on

    Tribute Pharmaceuticals Canada Inc. (OTCQB:TBUFF; TSX-V:TRX), Milton, Ontario Business: Autoimmune, Genitourinary, Diagnostic Date completed: 2014-07-15 Type: Follow-on Raised: C$30 million ($27.9 million) Units: 42.9 …

    Published on 7/28/2014
  • Aratana financial update

    Aratana Therapeutics Inc. (NASDAQ:PETX), Kansas City, Kan. Business: Veterinary Date announced: 2014-07-15 Note: Aratana filed a shelf registration covering up to $100 million of its securities. The company, which …

    Published on 7/28/2014
  • Bacterin financial update

    Bacterin International Holdings Inc. (NYSE-M:BONE), Belgrade, Mont. Business: Supply/Service Date announced: 2014-07-23 Note: Bacterin implemented a 1-for-10 reverse stock split. Following the split, the company has …

    Published on 7/28/2014
  • CorMedix financial update

    CorMedix Inc. (NYSE-M:CRMD), Summit, N.J. Business: Renal, Cardiovascular Date announced: 2014-07-24 Note: CorMedix said NYSE MKT granted the company an extension to May 31, 2015, to regain compliance with the …

    Published on 7/28/2014
  • Illumina financial update

    Illumina Inc. (NASDAQ:ILMN), San Diego, Calif. Business: Microarrays, Genomics, Supply/Service Date announced: 2014-07-23 Note: Illumina said it repurchased $72 million in shares under its share repurchase program. The …

    Published on 7/28/2014
  • InflaRx financial update

    InflaRx GmbH, Jena, Germany Business: Infectious Date announced: 2014-07-17 Note: InflaRx raised an undisclosed amount in the second and final tranche of a series B round, bringing the total raised in the round to the …

    Published on 7/28/2014
  • Inovio financial update

    Inovio Pharmaceuticals Inc. (NYSE-M:INO), Blue Bell, Pa. Business: Cancer, Infectious Date announced: 2014-07-23 Note: Inovio filed a shelf registration covering the sale of up to $175 million of its securities. The …

    Published on 7/28/2014
  • Matinas BioPharma financial update

    Matinas BioPharma Holdings Inc. (OTCBB:MTNB), Bedminster, N.J. Business: Cardiovascular Date announced: 2014-07-22 Note: Matinas began trading on the OTC Bulletin Board under the ticker MTNB. Previously, the company was…

    Published on 7/28/2014
  • Pixium Vision financial update

    Pixium Vision S.A. (Euronext:PIX), Paris, France Business: Ophthalmic Date announced: 2014-07-17 Note: Pixium raised EUR5 million ($6.7 million) through the sale of 598,575 shares at EUR8.28 to cover the overallotment …

    Published on 7/28/2014
  • Remiges BioPharma Fund L.P. financial update

    Remiges BioPharma Fund L.P., Cambridge, Mass. Business: Finance Date announced: 2014-07-08 Note: Remiges Ventures has raised $70 million of the targeted $150 million in its Remiges BioPharma Fund L.P., according to an …

    Published on 7/28/2014
  • Response Genetics financial update

    Response Genetics Inc. (NASDAQ:RGDX), Los Angeles, Calif. Business: Pharmacogenetics, Diagnostic Date announced: 2014-07-21 Note: Response Genetics filed a shelf registration covering the sale of up to $20 million of …

    Published on 7/28/2014
  • Sofinnova Ventures financial update

    Sofinnova Ventures, Menlo Park, Calif. Business: Finance Date announced: 2014-07-23 Note: Sofinnova Ventures raised $500 million for Sofinnova Venture Partners IX, its ninth fund and second life sciences-only fund. The …

    Published on 7/28/2014
  • Xagenic financial update

    Xagenic Inc., Toronto, Ontario Business: Diagnostic Date announced: 2014-07-14 Note: Xagenic raised C$5.5 million ($5.1 million) in the second close of a series B round, bringing the total raised in the round to C$25.5 …

    Published on 7/28/2014
  • KineMed withdraws IPO

    KineMed Inc., Emeryville, Calif. Business: Musculoskeletal, Neurology, Cardiovascular Date announced: 2014-07-23 Type: IPO Underwriters: Feltl; MLV & Co. LLC; Laidlaw & Co. Ltd. Note: KineMed withdrew its IPO on NASDAQ,…

    Published on 7/28/2014
  • Bio Blast Pharma amends IPO

    Bio Blast Pharma Ltd., Tel Aviv, Israel Business: Musculoskeletal Date announced: 2014-07-15 Type: IPO To be raised: Up to $43.3 million Shares: 3.3 million Price: $11-$13 Underwriters: Oppenheimer; Roth Capital …

    Published on 7/21/2014
  • Catalent amends IPO

    Catalent Inc., Somerset, N.J. Business: Supply/Service Date announced: 2014-07-18 Type: IPO To be raised: Up to $935 million Shares: 42.5 million Price: $19-$22 Underwriters: JPMorgan; Morgan Stanley; BofA Merrill Lynch…

    Published on 7/21/2014
  • CymaBay amends follow-on

    CymaBay Therapeutics Inc. (NASDAQ:CBAY), Newark, Calif. Business: Endocrine/Metabolic Date announced: 2014-07-17 Type: Follow-on To be raised: TBD Shares: 3.5 million Price prior: $7 Underwriters: Cowen; Stifel, …

    Published on 7/21/2014
  • Immune Design amends IPO

    Immune Design Corp., Seattle, Wash. Business: Infectious, Cancer Date announced: 2014-07-14 Type: IPO To be raised: Up to $65.1 million Shares: 4.7 million Price: $12-$14 Underwriters: Jefferies; Leerink Partners; Wells…

    Published on 7/21/2014
  • Innocoll amends IPO

    Innocoll GmbH, Athlone, Ireland Business: Drug delivery, Neurology, Infectious Date announced: 2014-07-15 Type: IPO To be raised: Up to $80.3 million Shares: 5.4 million Price: $13-$15 Underwriters: Piper Jaffray; …

    Published on 7/21/2014
  • Marinus amends IPO

    Marinus Pharmaceuticals Inc., New Haven, Conn. Business: Neurology Date announced: 2014-07-18 Type: IPO To be raised: Up to $56 million Shares: 4 million Price: $12-$14 Underwriters: Stifel, Nicolaus & Co.; JMP …

    Published on 7/21/2014
  • Microlin Bio amends IPO

    Microlin Bio Inc., New York, N.Y. Business: Cancer Date announced: 2014-07-15 Type: IPO To be raised: Up to $30.3 million Units: 5.5 million Price: $4.50-$5.50 (unit) Underwriters: Brean Capital; Summer Street; Meyers …

    Published on 7/21/2014
  • Pfenex amends IPO

    Pfenex Inc., San Diego, Calif. Business: Biosimilars, Supply/Service Date announced: 2014-07-17 Type: IPO To be raised: $65 million Shares: 8.1 million Price: $8 Underwriters: William Blair; JMP Securities; Mizuho …

    Published on 7/21/2014
  • Zosano amends IPO

    Zosano Pharma Corp., Fremont, Calif. Business: Drug delivery Date announced: 2014-07-16 Type: IPO To be raised: Up to $76.8 million Shares: 6.4 million Price: $10-$12 Underwriters: Wedbush; Ladenburg Thalmann; Roth …

    Published on 7/21/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993